Reddys Laboratories has launched Obeda, semaglutide injection following approval from the Drugs Controller General of India (DCGI), marking its entry into the fast-growing GLP-1 receptor agonist therapy segment
Cultivation conditions: Aerobic and anaerobic bacteria media (such as thioglycolate fluid media) were incubated at 30-35 for 14 days
stable at room temperature for short-term handling All materials are synthesized using state-of-the-art solid-phase peptide synthesis (SPPS) under ISO-certified laboratory conditions at Pepsynth Labs
Do not shake the vial, as vigorous agitation can cause the peptide to aggregate or denature
Important Safety Information Do not share your Ozempic pen with other people, even if the needle has been changed
Metabolic Research Focus: Commonly used in laboratory studies on glucose regulation, energy balance, and hormone signaling